Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients-Reference-Cited by-同舟云学术

Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients

Published:2018-06-23 Issue:8 Volume:67 Page:1285-1296
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Segatori Valeria I.^ORCID,Cuello Héctor A.,Gulino Cynthia A.,Albertó Marina,Venier Cecilia,Guthmann Marcelo D.,Demarco Ignacio A.,Alonso Daniel F.,Gabri Mariano R.^ORCID

Funder

Elea Laboratories

National University of Quilmes

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00262-018-2188-y/fulltext.html

Reference58 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108. https://doi.org/10.3322/caac.21262

2. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83(5):584–594. https://doi.org/10.4065/83.5.584

3. Tabchi S, Blais N, Campeau MP, Tehfe M (2017) Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer. Cancer Chemother Pharmacol 79(2):381–387. https://doi.org/10.1007/s00280-016-3226-0

4. Jackman DM, Miller VA, Cioffredi L-A, Yeap BY, Jänne PA, Riely GJ, Ruiz MG, Giaccone G, Sequist LV, Johnson BE (2009) Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials. Clin Cancer Res 15 (16):5267

5. Somasundaram A, Burns TF (2017) Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives. Lung Cancer 8:1–11. https://doi.org/10.2147/LCTT.S105678

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes-based immunotherapy for cancer: Effective components in the naïve and engineered forms;International Immunopharmacology;2024-09

2. Immune-inflammatory modulation by natural products derived from edible and medicinal herbs used in Chinese classical prescriptions;Phytomedicine;2024-07

3. Pathophysiological roles and applications of glycosphingolipids in the diagnosis and treatment of cancer diseases;Progress in Lipid Research;2023-07

4. Mimicry of Tumour-Associated Carbohydrates: Is It a Promising Option for Cancer Treatment?;Immuno;2023-03-23

5. Advances in the Lung Cancer Immunotherapy Approaches;Vaccines;2022-11-19